Image de couverture de livre

Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jeffrey V. Lazarus, Neil Parkin, Huma Qureshi, Benjamin LaBrot, John W. Ward
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Reviews in Medical Virology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource‐Limited Settings
par: Huma Qureshi, et autres
Publié: (2025)

Correction to “Agreement Between Dried Blood Spot and Plasma PCR in Infants With Congenital Cytomegalovirus Infection”
Publié: (2025)

Disruption of Signalling Pathways Induced by HBV HBx, HCV Core, and EBV LMP1 in Gastric Cancer
par: Mengli Gao, et autres
Publié: (2026)

Epidemiological Trends and CD4+T Cell Recovery in HIV‐1 Patients With HCV/HBV Co‐Infection: A Retrospective Cohort Study in Southwest China (2003–2024)
par: Xianwu Pang, et autres
Publié: (2025)

Strategic Approach to Enhancing Diagnostic Precision: Optimizing Panel Size for HBV and HCV Viral Load Monitoring Kits
par: Gauri Misra, et autres
Publié: (2025)

Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss
par: Fei Gu, et autres
Publié: (2024)

Hepatitis B Viral Rebound in People With HIV Under HBV‐Active Antiretroviral Therapy
par: Costanza Bertoni, et autres
Publié: (2025)

Longitudinal Changes in Immune Biomarkers Following Direct‐Acting Antiviral Therapy in HIV/HCV‐Coinfected Individuals in Indonesia
par: Evy Yunihastuti, et autres
Publié: (2025)

Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection
par: Weiyin Lin, et autres
Publié: (2024)

Hepatitis B Virus Genomic Variability & HBV‐Related Disease Outcomes: A Molecular Epidemiology Perspective
par: Maria Bousali, et autres
Publié: (2025)

The Effect of HBV Therapy on Glycemic Control in HBV‐Infected Patients With Diabetes: A 90‐day Multicenter Study
par: Qi Liu, et autres
Publié: (2025)

Association of HBV serological markers with host antiviral immune response relevant hepatic inflammatory damage in chronic HBV infection
par: Bei Jiang, et autres
Publié: (2024)

Extrathymic CD8 and CD4 Double Positive T Cells Presenting Vigorous HBV‐Specific Responses Accelerate HBV Clearance
par: Zhong Fang, et autres
Publié: (2025)

HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation
par: Chien‐Ming Chiang, et autres
Publié: (2025)

Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study
par: Miguel Moncayo, et autres
Publié: (2024)

Bilayer or Not: Revisiting the Structural Nature of HBV Subviral Particles
par: Haitao Liu, et autres
Publié: (2025)

Comparison of effectiveness and cost of different HCV testing strategies in high‐risk populations in China
par: Bing Chen, et autres
Publié: (2024)

Analysis of Blood Microbiome From People Living With HIV and Donors by 16S rRNA Metagenomic Sequencing
par: Qianqian Wei, et autres
Publié: (2025)

HBx/DTL Positive Feedback Loop Promotes HBV‐Related Hepatocellular Carcinoma Progression
par: Zhi‐Qin Xie, et autres
Publié: (2025)

A Novel Systemic Inflammation‐Based Model for Predicting Mortality in HBV‐Related ACLF
par: Wenting Peng, et autres
Publié: (2026)

Analysis of HBV Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule
par: Xi Zeng, et autres
Publié: (2026)

Fourth‐Generation HIV Rapid Tests: Enhanced Sensitivity and Reduced Diagnostic Window for HIV‐1 Primary Infection Screening
par: Vincent Guiraud, et autres
Publié: (2024)

TIM22 and TIM29 inhibit HBV replication by up‐regulating SRSF1 expression
par: Lin Guo, et autres
Publié: (2024)

GLS4 Induces the Interferon Signaling Pathway During Hepatitis B Virus (HBV) Infection
par: Lingzhu Zhao, et autres
Publié: (2026)

Plasma Proteomic Profiles of Pediatric Patients With Human Herpesvirus 6B Encephalitis Following Umbilical Cord Blood Transplantation
par: Kazunori Haruta, et autres
Publié: (2025)

Novel Function of NUP153 in HNF4α Transcriptional Upregulation Contributes to Promoting HBV Replication
par: Qianqian Jiang, et autres
Publié: (2025)

HIV‐1 RNA in Large and Small Plasma Extracellular Vesicles: A Novel Parameter for Monitoring Immune Activation and Virological Failure
par: Julien Boucher, et autres
Publié: (2025)

3D Radiomics Analysis Based on Liver CT Imaging for Predicting Hepatic Encephalopathy in HBV‐ACLF Patients
par: Xueyun Zhang, et autres
Publié: (2026)

Long‐term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB
par: Xiajie Wen, et autres
Publié: (2024)

HCC Model Induced by P53 and Pten Knockout in HBV‐Transgenic Mice Mirrors Human HCC at the Transcriptome Level
par: Zhao Chen, et autres
Publié: (2024)

Multi‐omics panoramic analysis of HBV integration, transcriptional regulation, and epigenetic modifications in PLC/PRF/5 cell line
par: Guiwen Guan, et autres
Publié: (2024)

Circulating Cell‐Free Mitochondrial DNA as a Prognostic Biomarker in Patients With HBV‐Related Acute‐on‐Chronic Liver Failure
par: Qiankun Hu, et autres
Publié: (2025)

Association between NTCP hepatic expression and inflammation/fibrosis as well as gender‐specific differences in chronic HBV‐infected patients
par: Jingyi Shi, et autres
Publié: (2024)

HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase
par: Lidan Hou, et autres
Publié: (2024)

TRPV4 promotes HBV replication and capsid assembly via methylation modification of H3K4 and HBc ubiquitin
par: Yu Zhang, et autres
Publié: (2024)

HBV Antigen‐Guided Switching Strategy From Nucleos(t)ide Analogue to Interferon: Avoid Virologic Breakthrough and Improve Functional Cure
par: Da Huang, et autres
Publié: (2024)

What is the real sword of HBV precore and basal core promoter mutations piercing the hepatocyte homeostasis: HBcAg or HBsAg?
par: Guixin Li, et autres
Publié: (2024)

An HBV‐Derived Peptide Poly6 as a Novel Candidate for Functional Cure Via IFN‐I–Mediated Epigenetic Regulation of cccDNA
par: Junghwa Jang, et autres
Publié: (2026)

Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429‐dependent m6A modification of CCR9
par: Zhao Lv, et autres
Publié: (2024)

Improved Safety of Nucleic Acid Amplification Technology Combined With Serological Tests for Screening Blood Donors: A Systematic Review and Meta‐Analysis
par: Heloise Skiavine Madeira, et autres
Publié: (2026)